Bailard’s AdaptHealth AHCO Stock Holding History

Bailard’s Portfolio AHCO Stock Details AHCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-21,058	Closed	-$210K	–	742
2025 Q4	$210K	Sell	21,058 -26,300	-56%	-$251K	﹤0.01%	706
2025 Q3	$424K	Buy	47,358 +5,300	+13%	+$49.1K	0.01%	530
2025 Q2	$397K	Buy	42,058 +12,358	+42%	+$109K	0.01%	545
2025 Q1	$322K	Buy	+29,700	New	+$299K	0.01%	551

Other funds holding AHCO

OCA

OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return

SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bailard's AHCO Position: Q1 2026 in Review

Bailard sold out of AdaptHealth (AHCO) in Q1 2026, closing a stake of 21,058 shares — an estimated $210K sold.

Bailard first reported a position in AHCO in Q1 2025 and held it in 4 quarters. The position peaked at $424K in Q3 2025. 241 funds tracked by Wall St. Rank hold AHCO as of Q1 2026.

Bailard reported no remaining AdaptHealth position as of Q1 2026 after selling out during the quarter.
Bailard sold 21,058 AdaptHealth shares in Q1 2026, an estimated $210K.
Bailard first reported a position in AdaptHealth in Q1 2025 and held it in 4 quarters.
Bailard's AdaptHealth position peaked at $424K in Q3 2025.
241 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2026.

Based on Bailard's 13F filing for Q1 2026, filed 11 May 2026.